Reduction in touch sensitivity and hyperinnervation in vesicant-injured rabbit eyelid by direct injection of corticotropin releasing factor

Neuroscience Letters

Volumn 400, Issue 1-2, 2006, Pages 30-34

  Harrison, Andrew R ^a   McLoon, Linda K ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

CRF; Neurogenic inflammation; Skin; Tissue injury

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR[9-41]; DOXORUBICIN; PROTEIN; PROTEIN PGP 9.5; SUBSTANCE P; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EYELID REFLEX; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; NERVE FIBER GROWTH; NEUROGENIC INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; TISSUE INJURY; TOUCH;

ANIMALS; BLINKING; CORTICOTROPIN-RELEASING HORMONE; DERMIS; DOXORUBICIN; EYELIDS; HORMONES; IMMUNOHISTOCHEMISTRY; NERVE FIBERS; RABBITS; SUBSTANCE P; TOUCH; UBIQUITIN THIOLESTERASE;

EID: 33646135298     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.02.023     Document Type: Article

References (28)

1. Bowers D.B., and Lynch J.B. Adriamycin extravasation. Plast. Reconstr. Surg. 61 (1978) 686-692
2. Bozkurt A., Ghandour S., Okboy N., Oner S., Arbak S., Coskun T., and Yegen B. Inflammatory response to cold injury in remote organs is reduced by corticotropin-releasing factor. Regul. Pept. 99 (2001) 131-139
3. Brack A., Rittner H.L., Machelska H., Leder K., Mousa S.A., Schafer M., and Stein C. Control of inflammatory pain by chemokine-mediated recruitment of opioid-containing polymorphonuclear cells. Pain 112 (2004) 229-238
4. Cabot P.J., Carter L., Schafter M., and Stein C. Methionine-enkephalin- and dynorphin A-release from immune cells and control of inflammatory pain. Pain 93 (2001) 207-212
5. Cepeda M.S., Bonney I., Moyano J., and Carr D.B. Corticotropin-releasing hormone produces analgesia in a thermal model independent of its effect on beta-endorphin and corticosterone. Regul. Pept. 118 (2004) 39-43
6. Correa S.G., Riera C.M., Spiess J., and Bianco I.D. Modulation of the inflammatory response by corticotropin-releasing factor. Eur. J. Pharmacol. 319 (1997) 85-90
7. Dalsgaard C.J., Rydh M., and Haegerstrand A. Cutaneous innervation in man visualized with protein gene product 9.5 antibodies. Histochemistry 92 (1989) 385-390
8. Gao G.C., Dashwood M.R., and Wei E.T. Corticotrophin-releasing factor inhibition of substance P-induced vascular leakage in rats: possible sites of action. Peptides 12 (1991) 639-644
9. Gu X.H., Terenghi G., Purkis P.E., Price D.A., Leigh I.M., and Polak J.M. Morphological changes of neural and vascular peptides in human skin suction blister injury. J. Pathol. 172 (1994) 61-72
10. Kiang J.G., and Wei E.T. Corticotropin-releasing factor inhibits thermal injury. J. Pharmacol. Exp. Ther. 243 (1987) 517-520
11. Lariviere W.R., and Melzack R. The role of corticotropin-releasing factor in pain and analgesia. Pain 84 (2000) 1-12
12. Li L., Xian C.J., Zhong J.H., and Zhou X.F. Lumber 5 ventral root transaction-induced upregulation of nerve growth factor in sensory neurons and their target tissues: a mechanism of neuropathic pain. Mol. Cell Neurosci. 23 (2003) 232-250
13. McLoon L.K., Sandnas A.M., Nockleby K., and Wirtschafter J.D. Reduction in vesicant-induced cellular inflammation and hyperalgesia by local injection of corticotropin releasing factor in rabbit eyelid. Inflamm. Res. 51 (2002) 16-23
14. McLoon L.K., and Wirtschafter J.D. Local injections of corticotropin releasing factor reduce doxorubicin-induced acute inflammation in the eyelid. Invest. Ophthalmol. Vis. Sci. 38 (1997) 834-841
15. Molliver D.C., Lindsay J., Albers K.M., and Davis B.M. Overexpression of NGF or GDNF alters transcriptional plasticity evoked by inflammation. Pain 113 (2005) 277-284
16. Mousa S.A., Bopaiah C.P., Stein C., and Schafer M. Involvement of corticotropin-releasing hormone receptor subtypes 1 and 2 in peripheral opioid-mediated inhibition of inflammatory pain. Pain 106 (2003) 297-307
17. Mousa S.A., Schafer M., Mitchell W.M., Hassan A., and Stein C. Local upregulation of corticotropin-releasing hormone and interleukin-1 receptors in rats with painful hindlimb inflammation. Eur. J. Pharmacol. 311 (1996) 221-231
18. Nolano M., Simone D.A., Wendelschafer-Crabb G., Johnson T., Hazen E., and Kennedy W.R. Topical capsaicin in humans: parallel loss of epidermal nerve fibers and pain sensation. Pain 81 (1999) 135-145
19. Park H.J., Kim H.J., Lee J.H., Lee J.Y., Cho B.K., Kang J.S., Kang H., Yang Y., and Cho D.H. Corticotropin-releasing hormone downregulates interleukin-18 expression in human HaCaT keratinocytes by activation of p38 mitogen-activated protein kinase pathway. J. Invest. Dermatol. 124 (2005) 751-755
20. Poree L.R., Dickenson A.H., and Wei E.T. Corticotropin-releasing factor inhibits the response of trigeminal neurons to noxious heat. Brain Res. 502 (1989) 349-355
21. Rudolph R., Stein R.S., and Pattillo R.A. Skin ulcers due to adriamycin. Cancer 37 (1976) 1087-1094
22. Schafer M., Carter L., and Stein C. Interleukin 1 and corticotropin releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 4219-4223
23. Slominski A., Ermak G., Hwang J., Chakraborty A., Mazurkiewicz J.E., and Mihm M. Proopiomelanocortin, corticotropin releasing hormone and corticotropin releasing hormone receptor genes are expressed in human skin. FEBS Lett. 374 (1995) 113-116
24. Stein C., Schafter M., and Machelska H. Attacking pain at its source: new perspectives on opioids. Nat. Med. 9 (2003) 1003-1008
25. Wacnik P.W., Baker C.M., Herron M.J., Kren T., Blazar B.R., Wilcox G.L., Hordinsky M.K., Beitz A.J., and Ericson M.E. Tumor-induced mechanical hyperalgesia involves CGRP receptors and altered innervation and vascularization of DsRed2 fluorescent hindpaw tumors. Pain 115 (2005) 95-106
26. Wei E.T., and Gao G.C. Corticotropin-releasing factor: an inhibitor of vascular leakage in rat skeletal muscle and brain cortex after injury. Regul. Pept. 333 (1991) 93-104
27. Wirtschafter J.D. Clinical doxorubicin chemomyectomy: an experimental treatment for muscle spasms. Ophthalmology 98 (1991) 357-366
28. Wirtschafter J.D., and McLoon L.K. Long term efficacy of local doxorubicin injections in eyelid spasm patients. Ophthalmology 105 (1998) 342-346